The overexpression of LSD1 in AML contributes to the suppression of tumor suppressor genes, thereby enhancing leukemia cell survival and increasing resistance to chemotherapy (Jafek et al., 2019; Wass et al., 2021). The gene discussed is KDM1A; the disease is acute myeloid leukemia.